Breaking News Instant updates and real-time market news.

INFN

Infinera

$3.06

-0.05 (-1.61%)

, CREE

Cree

$54.31

-0.83 (-1.51%)

10:05
06/03/19
06/03
10:05
06/03/19
10:05

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Infinera (INFN) downgraded to Underweight from Neutral at JPMorgan with analyst Samik Chatterjee saying he sees a "heightened level of near-term and medium-term risks from the much more moderate level" of capex spending from cable customers. 2. Cree (CREE) downgraded to Market Perform from Outperform at BMO Capital with analyst Ambrish Srivastava saying he believes Cree is executing solidly on its transformation but finds the stock's risk/reward profile as fairly balanced at current levels. 3. Fortive (FTV) downgraded to Underperform from Market Perform at Cowen. 4. Big Lots (BIG) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Haas saying the company's outlook for the rest of the year may be too optimistic and could be cut further. 5. Emerald Expositions Events (EEX) downgraded to Neutral from Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

INFN

Infinera

$3.06

-0.05 (-1.61%)

CREE

Cree

$54.31

-0.83 (-1.51%)

FTV

Fortive

$74.46

-1.73 (-2.27%)

BIG

Big Lots

$26.93

-0.64 (-2.32%)

EEX

Emerald Expositions Events

$11.23

-0.45 (-3.85%)

  • 04

    Jun

  • 10

    Jun

  • 20

    Aug

INFN Infinera
$3.06

-0.05 (-1.61%)

06/03/19
JPMS
06/03/19
DOWNGRADE
JPMS
Underweight
Infinera downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Samik Chatterjee downgraded Infinera to Underweight from Neutral.
06/03/19
JPMS
06/03/19
DOWNGRADE
JPMS
Underweight
JPMorgan downgrades Infinera to Underweight on slowing cable spending
JPMorgan analyst Samik Chatterjee downgraded Infinera to Underweight from Neutral without a price target. The analyst sees a "heightened level of near-term and medium-term risks from the much more moderate level" of capex spending from cable customers. This is in addition to the already existing long-term risks relative to the acquisition, Chatterjee tells investors in a research note.
03/28/19
UBSW
03/28/19
NO CHANGE
Target $64
UBSW
Buy
Acacia Communications price target raised to $64 from $56 at UBS
UBS analyst Tejas Venkatesh raised his price target on Acacia Communications (ACIA) to $64 and kept his Buy rating, citing his increased confidence in the company's growth. The analyst points to the company's "concurrent product cycles" being in the early stages, its rising cloud market content, and its "new data center interconnect customers like Cisco (CSCO) and Infinera (INFN)". Venkatesh contends that Acacia Communications can achieve 2019 EPS of $1.80 vs. the current consensus of $1.50.
05/07/19
PIPR
05/07/19
NO CHANGE
Target $69
PIPR
Overweight
Fabrinet target raised to $69 on 'impressive' results at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Fabrinet (FN) to $69 from $67 saying the company reported "impressive" March quarter results with revenue and earnings "comfortably" beating consensus expectations. Demand for telco optics remained strong in the quarter and the company is now turning modestly more upbeat regarding second half of the year strength for datacom optics, Jensen tells investors in a research note. Further, Fabrinet also announced a material win with Infinera (INFN), adds the analyst. He reiterates an Overweight rating on the shares.
CREE Cree
$54.31

-0.83 (-1.51%)

05/02/19
05/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hilton (HLT) downgraded to Hold from Buy at Deutsche Bank with analyst Carlo Santarelli saying he's making a stock call on valuation, not a company call. He expects the stock to take a "breather" following the post-earnings rally. 2. Estee Lauder (EL) was downgraded to Sector Perform from Outperform at RBC Capital and to Neutral from Buy at DA Davidson. 3. Scotts Miracle-Gro (SMG) downgraded to Underperform from Neutral at BofA/Merrill with analyst Christopher Carey saying Scotts reported "solid" Q1 results, but he is concerned about difficult comps ahead and market expectations for a guidance raise. 4. GrubHub (GRUB) downgraded to Hold from Buy at Argus with analyst John Staszak saying he believes that the company will see higher costs and margin pressure as it enters new markets and also warns that differentiation challenges relative to the emerging competition could slow its growth rate over the coming several years. 5. Cree (CREE) downgraded to Perform from Outperform at Oppenheimer wth analyst Colin Rusch saying management has executed well on its turnaround plan, but this is currently reflected in the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/02/19
OPCO
05/02/19
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades Cree with turnaround priced into shares
Oppenheimer analyst Colin Rusch downgraded Cree to Perform from Outperform without a price target. Management has executed well on its turnaround plan, but this is currently reflected in the shares, Rusch tells investors in a research note. He believes upside from current stock levels would require Cree to successfully compete with its customers in serving the transportation sector with power conversion devices. Citing a lack of visibility into awards from auto manufacturers and uncertainty around the LED business, Rusch steps to the sidelines with respect to Cree shares.
06/03/19
BMOC
06/03/19
DOWNGRADE
Target $55
BMOC
Market Perform
Cree downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Ambrish Srivastava downgraded Cree to Market Perform from Outperform with an unchanged price target of $55. The analyst believes Cree is executing solidly on its transformation but finds the stock's risk/reward profile as fairly balanced at current levels. Srivastava's upside scenario suggests the stock could go to $70 and his downside scenario suggests a price of $43.
05/02/19
ADAM
05/02/19
NO CHANGE
Target $78
ADAM
Buy
Cree price target lowered to $78 from $81 at Canaccord
Canaccord analyst Jed Dorsheimer lowered his price target for Cree to $78 from $81 and maintained a Buy rating following the company's Q3 earnings report, saying that while Cree continues to see strong secular growth opportunities for the Wolfspeed business, softer Q4 guidance reflects the inevitable lumpiness associated with early adoption of this secular trend. Dorsheimer tells investors in a research note that he continues to view Cree as well positioned as the SiC value proposition remains strong in battery EV, but recognizes the early nature of a potential ramp.
FTV Fortive
$74.46

-1.73 (-2.27%)

05/08/19
MSCO
05/08/19
DOWNGRADE
Target $88
MSCO
Equal Weight
Fortive downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Joshua Pokrzywinski downgraded Fortive to Equal Weight from Overweight citing the stock's valuation after a 29% year-to-date advance as well as the sector valuation of "high quality industrials," like Fortive, which he notes are at elevated levels compared to more cyclical names. Pokrzywinski also noted that 2019 earnings growth assumes a strong ramp in profitability in the second half, leaving less room for upside. He trimmed his price target on Fortive shares to $88 from $89.
05/15/19
BREN
05/15/19
INITIATION
Target $96
BREN
Buy
Fortive initiated with a Buy at Berenberg
Berenberg analyst Andrew Buscaglia initiated Fortive (FTV) with a Buy rating and $96 price target, stating that he believes the company will prove to be the leader of the next generation of multi-industry industrials and the stock "provides a second chance" to own a stock like Danaher (DHR), from which Fortive was spun-out. Buscaglia also thinks synergies are just beginning from Fortive's portfolio transformation, he noted.
06/03/19
COWN
06/03/19
DOWNGRADE
Target $65
COWN
Underperform
Fortive downgraded to Underperform from Market Perform at Cowen
Cowen analyst Joseph Giordano downgraded Fortive to Underperform from Market Perform and lowered his price target for the shares to $65 from $75.
05/08/19
05/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mylan (MYL) downgraded to Market Perform from Outperform at Wells Fargo with analyst David Maris saying Mylan reported "disappointing" results which missed consensus on several key metrics including revenue and revenue by segment. 2. Inogen (INGN) downgraded to Neutral from Overweight at JPMorgan with analyst Robert Marcus saying the company's in-line Q1 results were overshadowed by a $25M reduction to guidance. 3. Fortive (FTV) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Joshua Pokrzywinski citing the stock's valuation after a 29% year-to-date advance as well as the sector valuation of "high quality industrials". 4. Farmer Bros. (FARM) downgraded to Neutral from Buy at Roth Capital with analyst Gerry Sweeney saying the company's results were hurt by significant operating issues and Mike Keown stepped down as CEO. 5. 2U (TWOU) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick noting the company reported Q1 and lowered its fiscal year revenue guidance, primarily accounting for schools tightening their admissions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BIG Big Lots
$26.93

-0.64 (-2.32%)

05/24/19
05/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Avon Products (AVP) downgraded to Neutral from Buy at DA Davidson. 2. SQM (SQM) downgraded to Market Perform from Outperform at BMO Capital with analyst Joel Jackson saying a lithium rebound or a bottoming in sentiment may take longer and that the company's earnings trajectory no longer warrants a bullish outlook. 3. Lennox (LII) downgraded to Sell from Neutral at UBS with analyst Damian Karas saying the company is trading at a "peak multiple on peak growth." 4. Weibo (WB) downgraded to Reduce from Hold at HSBC. 5. Big Lots (BIG) downgraded to Neutral from Overweight at Piper Jaffray with analyst Peter Keith saying the downgrade is based on risk to first half of 2019 estimates as well as ongoing tariff concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/03/19
BOFA
06/03/19
DOWNGRADE
Target $23
BOFA
Underperform
Big Lots downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Jason Haas double downgraded Big Lots to Underperform from Buy and cut his price target for the shares to $23 from $45. The company's outlook for the rest of the year may be too optimistic and could be cut further, Haas tells investors in a research note. The analyst believes shares of Big Lots "will continue to struggle" until consistent improvement in earnings growth is demonstrated.
05/24/19
PIPR
05/24/19
DOWNGRADE
Target $31
PIPR
Neutral
Big Lots downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Big Lots to Neutral from Overweight and lowered his price target for the shares to $31 from $44. The analyst says the downgrade is based on risk to first half of 2019 estimates as well as ongoing tariff concerns. The analyst believes Big Lots' Q1 was "in-line at best" and that Q2 "appears to have stepped up markdown activity." On tariffs, Big Lots imports 21% of sales from China with a majority now getting tariffed at 25%, Keith tells investors in a research note.
06/03/19
RAJA
06/03/19
NO CHANGE
Target $40
RAJA
Outperform
Big Lots estimates for Q2, FY raised at Raymond James
Raymond James analyst Dan Wewer reiterated an Outperform rating and $40 price target on Big Lots following the company's quarterly earnings report. In a research note to investors, Wewer says Big Lots is pursuing a number of promising initiatives that are beginning to benefit the company's top-line growth, but believes rising expenses tied to these initiatives will pressure EBIT and EPS for a second consecutive year. He raised his Q2 EPS forecast to 39c from 37c, in line with management's guidance, and raised his FY19 EPS outlook to $3.84 from $3.75, at the high end of management's revised guidance.
EEX Emerald Expositions Events
$11.23

-0.45 (-3.85%)

01/18/19
LEHM
01/18/19
DOWNGRADE
Target $12
LEHM
Underweight
Emerald Expositions downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Manav Patnaik downgraded Emerald Expositions Events to Underweight with a $12 price target.
06/03/19
GSCO
06/03/19
DOWNGRADE
Target $14.16
GSCO
Neutral
Emerald Expositions Events downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Katherine Tait downgraded Emerald Expositions Events to Neutral from Buy and lowered her price target for the shares to $14.16 from $15.16.
01/18/19
LEHM
01/18/19
DOWNGRADE
Target $12
LEHM
Underweight
Barclays downgrades Emerald Exposition to Underweight on 'uninspiring' trends
Barclays analyst Manav Patnaik downgraded Emerald Expositions Events to Underweight from Equal Weight with an unchanged price target of $12. The company's near-term trends "remain uninspiring," and by the time the company regains credibility, we could be facing recessionary concerns, Patnaik tells investors in a research note. He adds that the stock has run past his price target.
01/24/19
DBAB
01/24/19
NO CHANGE
DBAB
Hold
Emerald Expositions a 'difficult acquisition target,' says Deutsche Bank
Post the announced acquisition of Mack Brooks by Relx (RELX) on January 15, shares of Emerald Expositions Events (EEX) have rallied, as investors may view it as a potential acquisition target, Deutsche Bank analyst Ashish Sabadra tells investors in a research note. In addition, Emerald hasn't provided an update on the CEO search, which increases the perceived likelihood of any potential deal, says the analyst. However, Sabadra believes challenges at its top two shows and its exposure to U.S. consumer end markets make Emerald Expositions a "difficult acquisition target." He keeps a Hold rating on the shares.

TODAY'S FREE FLY STORIES

ZM

Zoom Video

$70.27

-0.56 (-0.79%)

, PINS

Pinterest

$24.76

-1.215 (-4.68%)

10:11
10/15/19
10/15
10:11
10/15/19
10:11
Hot Stocks
Zoom Video, Pinterest slip as lock-ups for IPOs expire »

Shares of both Zoom Video…

ZM

Zoom Video

$70.27

-0.56 (-0.79%)

PINS

Pinterest

$24.76

-1.215 (-4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 31

    Oct

  • 19

    Nov

  • 16

    Dec

C

Citi

$69.93

-0.35 (-0.50%)

10:11
10/15/19
10/15
10:11
10/15/19
10:11
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi CFO says to expand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 12

    Nov

KNX

Knight-Swift

$35.47

-0.575 (-1.60%)

10:08
10/15/19
10/15
10:08
10/15/19
10:08
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift guidance cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

C

Citi

$69.90

-0.38 (-0.54%)

10:07
10/15/19
10/15
10:07
10/15/19
10:07
Hot Stocks
Citi says environment is 'highly unpredictable,' waters 'choppy' »

CEO Mike Corbat says the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 12

    Nov

10:07
10/15/19
10/15
10:07
10/15/19
10:07
Conference/Events
JPMorgan agricultural/machinery analyst holds analyst/industry conference call »

Machinery Equity Analyst…

TLRY

Tilray

$22.00

1.35 (6.54%)

10:05
10/15/19
10/15
10:05
10/15/19
10:05
Options
Tilray call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TNDM

TNDM

, ABT

Abbott

$81.63

1.82 (2.28%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Recommendations
TNDM, Abbott, DexCom analyst commentary  »

Tandem, Abbott agreement…

TNDM

TNDM

ABT

Abbott

$81.63

1.82 (2.28%)

DXCM

DexCom

$147.49

-12.71 (-7.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

GM

General Motors

$35.28

-0.23 (-0.65%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Periodicals
Breaking Periodicals news story on General Motors »

GM near agreement with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UNH

UnitedHealth

$233.77

13.45 (6.10%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
UnitedHealth rises 5.9% »

UnitedHealth is up 5.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

DS

Drive Shack

$4.01

0.28 (7.51%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
Drive Shack rises 7.0% »

Drive Shack is up 7.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.26

0.93 (21.48%)

10:00
10/15/19
10/15
10:00
10/15/19
10:00
Hot Stocks
Aphria rises 20.9% »

Aphria is up 20.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

WIT

Wipro

$3.76

0.07 (1.90%)

09:59
10/15/19
10/15
09:59
10/15/19
09:59
Earnings
Wipro sees Q3 IT Services business revenue $2.065B-$2.106B »

For the quarter ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

WIT

Wipro

$3.76

0.07 (1.90%)

09:57
10/15/19
10/15
09:57
10/15/19
09:57
Earnings
Wipro reports Q2 EPS 6c, consensus 6c »

Reports Q2 revenue $2.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

UNH

UnitedHealth

$233.50

13.18 (5.98%)

, ANTM

Anthem

$244.77

10.04 (4.28%)

09:55
10/15/19
10/15
09:55
10/15/19
09:55
Options
Early notable gainers among liquid option names on October 15th »

Notable gainers among…

UNH

UnitedHealth

$233.50

13.18 (5.98%)

ANTM

Anthem

$244.77

10.04 (4.28%)

CI

Cigna

$157.49

5.875 (3.87%)

SCHW

Charles Schwab

$38.63

0.89 (2.36%)

NVDA

Nvidia

$192.32

5.81 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 31

    Oct

  • 20

    Nov

EMR

Emerson

$66.89

-0.32 (-0.48%)

09:54
10/15/19
10/15
09:54
10/15/19
09:54
Hot Stocks
D. E. Shaw sees 50% upside in Emerson shares, calls for cost cuts and split »

D. E. Shaw Group, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

JNJ

Johnson & Johnson

$132.66

1.99 (1.52%)

09:53
10/15/19
10/15
09:53
10/15/19
09:53
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

EMR

Emerson

$67.03

-0.18 (-0.27%)

09:51
10/15/19
10/15
09:51
10/15/19
09:51
Hot Stocks
Breaking Hot Stocks news story on Emerson »

D.E. Shaw calls for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

TNDM

TNDM

, ABT

Abbott

$81.63

1.82 (2.28%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
TNDM, Abbott, DexCom, Insulet analyst commentary  »

Abbott partnership a…

TNDM

TNDM

ABT

Abbott

$81.63

1.82 (2.28%)

DXCM

DexCom

$153.56

-6.64 (-4.14%)

PODD

Insulet

$154.02

1.72 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

AMBA

Ambarella

$56.30

3.19 (6.01%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
Ambarella analyst commentary  »

KeyBanc boosts Ambarella…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

09:50
10/15/19
10/15
09:50
10/15/19
09:50
General news
IMF's global growth outlooks were trimmed »

IMF's global growth…

NR

Newpark Resources

$6.77

-0.155 (-2.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Newpark Resources falls -5.3% »

Newpark Resources is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

MTW

Manitowoc

$10.71

-0.68 (-5.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Manitowoc falls -5.9% »

Manitowoc is down -5.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$40.25

-6 (-12.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
PagSeguro Digital falls -13.7% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

  • 17

    Oct

UNH

UnitedHealth

$233.30

12.98 (5.89%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
UnitedHealth rises 5.7% »

UnitedHealth is up 5.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

FRC

First Republic

$103.44

6.08 (6.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
First Republic rises 6.0% »

First Republic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.